TCIM
TIAA CREF Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $185M | Buy |
1,005,656
+12,369
| +1% | +$2.28M | 0.13% | 159 |
|
|
2018
Q4 | $165M | Sell |
993,287
-440,752
| -31% | -$73M | 0.13% | 156 |
|
|
2018
Q3 | $276M | Sell |
1,434,039
-371,272
| -21% | -$71.6M | 0.18% | 121 |
|
|
2018
Q2 | $307M | Buy |
1,805,311
+189,401
| +12% | +$32.2M | 0.21% | 107 |
|
|
2018
Q1 | $263M | Sell |
1,615,910
-275,572
| -15% | -$44.9M | 0.18% | 121 |
|
|
2017
Q4 | $283M | Sell |
1,891,482
-267,106
| -12% | -$40M | 0.19% | 110 |
|
|
2017
Q3 | $328M | Buy |
2,158,588
+81,285
| +4% | +$12.4M | 0.22% | 98 |
|
|
2017
Q2 | $268M | Buy |
2,077,303
+456,290
| +28% | +$58.8M | 0.19% | 114 |
|
|
2017
Q1 | $177M | Buy |
1,621,013
+321,513
| +25% | +$35.2M | 0.13% | 168 |
|
|
2016
Q4 | $95.7M | Sell |
1,299,500
-102,209
| -7% | -$7.53M | 0.07% | 281 |
|
|
2016
Q3 | $122K | Sell |
1,401,709
-230,372
| -14% | -$20.1K | 0.08% | 249 |
|
|
2016
Q2 | $140M | Buy |
1,632,081
+412,067
| +34% | +$35.4M | 0.11% | 201 |
|
|
2016
Q1 | $97M | Sell |
1,220,014
-371,748
| -23% | -$29.6M | 0.07% | 270 |
|
|
2015
Q4 | $200M | Buy |
1,591,762
+23,099
| +1% | +$2.91M | 0.15% | 146 |
|
|
2015
Q3 | $163M | Sell |
1,568,663
-115,907
| -7% | -$12.1M | 0.13% | 165 |
|
|
2015
Q2 | $208M | Buy |
1,684,570
+478,866
| +40% | +$59.1M | 0.15% | 156 |
|
|
2015
Q1 | $142M | Buy |
1,205,704
+216,514
| +22% | +$25.5M | 0.1% | 234 |
|
|
2014
Q4 | $118M | Sell |
989,190
-60,678
| -6% | -$7.21M | 0.08% | 272 |
|
|
2014
Q3 | $118M | Sell |
1,049,868
-71,668
| -6% | -$8.05M | 0.08% | 258 |
|
|
2014
Q2 | $106M | Sell |
1,121,536
-18,992
| -2% | -$1.8M | 0.07% | 290 |
|
|
2014
Q1 | $80.7M | Sell |
1,140,528
-245,571
| -18% | -$17.4M | 0.06% | 353 |
|
|
2013
Q4 | $103M | Sell |
1,386,099
-424,087
| -23% | -$31.5M | 0.07% | 287 |
|
|
2013
Q3 | $137M | Sell |
1,810,186
-171,066
| -9% | -$13M | 0.11% | 203 |
|
|
2013
Q2 | $158M | Buy |
+1,981,252
| New | +$158M | 0.13% | 174 |
|